Molecular Mimicry in Immune Mediated Neurologic Disease

免疫介导的神经系统疾病中的分子拟态

基本信息

  • 批准号:
    8536552
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-01 至 2016-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this research is to elucidate novel mechanisms of neurodegeneration related to the pathogenesis of progressive forms of multiple sclerosis (MS), a common cause of disability in United States Veterans. Considering there are no treatments for progressive MS, a comprehensive understanding of the role of neurodegeneration in its pathogenesis should lead to novel therapeutic strategies to treat MS, thereby reducing disability. The purpose of this proposal is to examine how antibodies to RNA binding proteins (RBPs) cause neurodegeneration in MS. RBPs are critical to the normal function of neurons and have been recently implicated in the pathogenesis of neurodegenerative disease like amyotropic lateral sclerosis and dementia. However, there are little data on the role that RBPs play in neurodegeneration in immune-mediated diseases like MS. Many studies have implicated a number of viral triggers as a cause of MS, yet, no single virus has been exclusively shown to cause MS. Given this, human and animal viral models of MS are used to study its pathogenesis. One example is human T-lymphotropic virus type-1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP). HAM/TSP is similar clinically, pathologically, and immunologically to progressive MS and thus is a relevant model to study it. HAM/TSP patients were found to make antibodies to heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), an RBP overexpressed in neurons. Importantly, MS patients were also found to make antibodies to hnRNP A1. Anti-hnRNP A1 antibodies reduced neuronal firing and caused neurodegeneration in neuronal cell lines, suggesting that these antibodies are pathogenic. Further, microarray analyses of neurons exposed to anti-hnRNP A1 antibodies altered hnRNP A1 function and revealed novel pathways of neurodegeneration. Specifically, there was downregulation of RNA levels of the spinal paraplegia genes (SPGs). SPGs contribute to normal neuronal function and axonal transport. Dysregulation of axonal transport results in neurodegeneration. Mutations in SPGs cause hereditary spastic paraparesis, genetic disorders clinically indistinguishable from progressive MS and HAM/TSP. Thus, there is a strong association between involvement of SPGs in neurodegeneration and the clinical phenotype of progressive MS and HAM/TSP patients, who commonly develop spastic paraparesis. The objective of this grant is to examine how anti-hnRNP A1 antibodies cause neurodegeneration. This will be accomplished by completing the following specific aims: 1. Determine the sensitivity and specificity of anti-hnRNP A1 antibodies as a diagnostic test for MS. 2. Examine molecular interactions between hnRNP A1 and target genes to determine their role in neuronal function and neurodegeneration. 3. Test for the pathogenicity of anti-hnRNP A1 antibodies using in vivo models of neurodegeneration. A serum test that can diagnose MS has yet to be discovered. Our data indicate that anti-hnRNP A1 antibodies can be used to diagnose MS. Anti-hnRNP A1 antibodies might also contribute to neurodegeneration and the pathogenesis of MS. The combination of both a diagnostic and pathogenic immune reaction is of particular relevance and has the potential to make important contributions to the long- term care and outcomes of people with MS.
描述(由申请人提供): 这项研究的长期目标是阐明与进行性多发性硬化症(MS)发病机制相关的神经退行性新机制,多发性硬化症是美国退伍军人残疾的常见原因。考虑到进行性多发性硬化症尚无治疗方法,全面了解神经变性在其发病机制中的作用应该会导致治疗多发性硬化症的新治疗策略,从而减少残疾。该提案的目的是研究 RNA 结合蛋白 (RBP) 的抗体如何导致多发性硬化症的神经变性。 RBP 对神经元的正常功能至关重要,最近被认为与肌萎缩侧索硬化症和痴呆等神经退行性疾病的发病机制有关。然而,关于 RBP 在免疫介导疾病(如多发性硬化症)的神经变性中所起的作用的数据很少。许多研究表明多种病毒触发因素是多发性硬化症的病因,但目前还没有单一病毒被证明可以单独引起多发性硬化症。鉴于此,人类和动物多发性硬化症病毒模型被用来研究其发病机制。一个例子是人类 T 淋巴细胞病毒 1 型 (HTLV-1) 相关的脊髓病/热带痉挛性截瘫 (HAM/TSP)。 HAM/TSP 在临床、病理学和免疫学上与进行性 MS 相似,因此是研究它的相关模型。研究发现 HAM/TSP 患者会产生针对异质核核糖核蛋白 A1 (hnRNP A1) 的抗体,这是一种在神经元中过度表达的 RBP。重要的是,多发性硬化症患者也被发现产生 hnRNP A1 抗体。抗 hnRNP A1 抗体减少神经元放电并引起神经元细胞系神经变性,表明这些抗体具有致病性。此外,暴露于抗 hnRNP A1 抗体的神经元的微阵列分析改变了 hnRNP A1 功能,并揭示了神经退行性变的新途径。具体来说,脊髓截瘫基因 (SPG) 的 RNA 水平下调。 SPG 有助于正常的神经元功能和轴突运输。轴突运输失调导致神经变性。 SPG 突变会导致遗传性痉挛性截瘫,这种遗传性疾病在临床上与进行性 MS 和 HAM/TSP 无法区分。因此,SPG 参与神经变性与进行性 MS 和 HAM/TSP 患者的临床表型之间存在密切关联,这些患者通常会出现痉挛性截瘫。这笔资助的目的是研究抗 hnRNP A1 抗体如何引起神经变性。这将通过完成以下具体目标来实现: 1. 确定抗 hnRNP A1 抗体作为 MS 诊断测试的敏感性和特异性。 2. 检查 hnRNP A1 和靶基因之间的分子相互作用,以确定它们在神经元功能和神经变性中的作用。 3.使用神经变性体内模型测试抗hnRNP A1抗体的致病性。尚未发现可以诊断多发性硬化症的血清测试。我们的数据表明抗 hnRNP A1 抗体可用于诊断 MS。抗 hnRNP A1 抗体也可能导致神经变性和 MS 的发病机制。诊断和致病性免疫反应的结合具有特别重要的意义,并且有可能对多发性硬化症患者的长期护理和结果做出重要贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Levin其他文献

Michael Levin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Levin', 18)}}的其他基金

Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB
儿童结核病生物标志物的验证和进一步开发用于诊断儿童结核病
  • 批准号:
    10062471
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8680007
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8971987
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8774197
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help
通过基于网络的引导式自助在大学中应用正念和接受
  • 批准号:
    8122484
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了